ISIN | LU1585229187 |
---|---|
Valorennummer | |
Bloomberg Global ID | |
Fondsname | Bellevue Emerging Markets Healthcare B |
Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fondsanbieter | Bellevue Asset Management AG |
Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
Besonderheiten |
Aktueller Preis * | 122.40 EUR | 13.09.2024 |
---|---|---|
Vorheriger Preis * | 119.00 EUR | 09.09.2024 |
52 Wochen Hoch * | 138.03 EUR | 08.11.2023 |
52 Wochen Tief * | 108.97 EUR | 31.05.2024 |
NAV * | 122.40 EUR | 13.09.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 77'101'315 | |
Anteilsklassevermögen *** | ||
Trading Information SIX |
YTD-Performance | -5.12% |
29.12.2023 - 13.09.2024
29.12.2023 13.09.2024 |
---|---|---|
YTD-Performance (in CHF) | -3.81% |
29.12.2023 - 13.09.2024
29.12.2023 13.09.2024 |
1 Monat | +2.50% |
13.08.2024 - 13.09.2024
13.08.2024 13.09.2024 |
3 Monate | +7.66% |
13.06.2024 - 13.09.2024
13.06.2024 13.09.2024 |
6 Monate | +0.02% |
14.03.2024 - 13.09.2024
14.03.2024 13.09.2024 |
1 Jahr | -7.57% |
13.09.2023 - 13.09.2024
13.09.2023 13.09.2024 |
2 Jahre | -17.64% |
13.09.2022 - 13.09.2024
13.09.2022 13.09.2024 |
3 Jahre | -38.45% |
13.09.2021 - 13.09.2024
13.09.2021 13.09.2024 |
5 Jahre | -44.35% |
15.06.2021 - 13.09.2024
15.06.2021 13.09.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Innovent Biologics Inc | 6.61% | |
---|---|---|
Sun Pharmaceuticals Industries Ltd | 5.99% | |
Legend Biotech Corp ADR | 5.90% | |
Samsung BioLogics Co Ltd | 5.70% | |
CSPC Pharmaceutical Group Ltd | 5.69% | |
Celltrion Inc | 5.49% | |
Apollo Hospitals Enterprise Ltd | 4.31% | |
Cipla Ltd | 3.35% | |
Chemical Works of Gedeon Richter PLC | 3.28% | |
Hapvida Participacoes Investimento SA Ordinary Shares | 2.97% | |
Letzte Daten-Aktualisierung | 31.07.2024 |
TER | 2.26% |
---|---|
Datum TER | 29.01.2021 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.24% |
SRRI ***
|
|
Datum SRRI *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |